Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02958267 · ClinicalTrials.gov registry record · Phase 2
Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee
A Phase 2 study, sponsored by OhioHealth.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT02958267 is a Phase 2 study that has completed, run by OhioHealth. The registered enrollment target is 32 participants.
The verdict
NCT02958267, a Phase 2 study, has completed, sponsored by OhioHealth.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical response to autologous bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) injections for knee osteoarthritis with respect to pain, function, and quality of life at up to 1 year following the intervention. Specifically, the clinical response will be compared to baseline and a control group treated with a Gel-One® hyaluronate injection to the target knee.
Interventions
- BIOLOGICAL BMAC injection
- BIOLOGICAL PRP injection
- DEVICE Gel-One® hyaluronate injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02958267
The ClinicalTrials.gov registry entry for NCT02958267 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BMAC injection is the first listed.
NCT02958267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02958267 about?
NCT02958267 is a clinical study titled "Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee". The purpose of this study is to determine the clinical response to autologous bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) injections for knee osteoarthritis with respect to pain, function, and quality of life at up to 1 year following the intervention. Specifically, the cl...
What is the current status of trial NCT02958267?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2016-12. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02958267?
The interventions under investigation include: BMAC injection (BIOLOGICAL), PRP injection (BIOLOGICAL), Gel-One® hyaluronate injection (DEVICE).
Who is sponsoring clinical trial NCT02958267?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.